Zoetis Inc. is a global leader in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The company operates through two primary segments: the United States and International.
Founded in 1952 as a division of Pfizer, Zoetis became an independent company in 2013. It's headquartered in Parsippany, New Jersey, United States.
Zoetis specializes in the production of a wide range of veterinary vaccines and medicines, including anti-infectives, vaccines, parasite control, and pain management drugs.
|Ms. Kristin C. Peck||CEO & Director||2.8M||3.05M||1971|
|Mr. Wetteny N. Joseph||Executive VP & CFO||1.26M||N/A||1972|
|Ms. Wafaa Mamilli||EVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health||1.08M||N/A||1967|
|Ms. Heidi C. Chen||Executive VP, General Counsel, Corporate Secretary & Business Lead of Human Health Diagnostics||1.04M||N/A||1967|
|Ms. Roxanne Lagano||Executive VP and Chief Human Resources Officer & Global Operations||N/A||N/A||1965|
|Mr. Steven Frank||Vice President of Investor Relations||N/A||N/A||N/A|
|Mr. William Price||VP & Chief Communications Officer||N/A||N/A||N/A|
|Dr. Robert J. Polzer Ph.D.||Executive VP and President of Research & Development||N/A||N/A||1969|
|Ms. Jeannette Ferran Astorga||Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer||N/A||N/A||1975|
|Mr. Nick Ashton||Executive VP and President of Global Manufacturing & Supply||N/A||N/A||1973|